A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause

NCT06206421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Hot Flashes

Interventions

DRUG: Fezolinetant
DRUG: Placebo

Sponsor

Astellas Pharma Inc